Glenn Welling’s DexCom DXCM Stock Holding History

Glenn Welling’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-240,000	Closed	-$2.94M	–	17
2017 Q3	$2.94M	Buy	+240,000	New	+$4.24M	0.36%	19

Other funds holding DXCM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Glenn Welling's DXCM Position: Q4 2017 in Review

Glenn Welling sold out of DexCom (DXCM) in Q4 2017, closing a stake of 240,000 shares — an estimated $2.94M sold.

Glenn Welling first reported a position in DXCM in Q3 2017 and held it in 1 quarter. The position peaked at $2.94M in Q3 2017. 273 funds tracked by Wall St. Rank hold DXCM as of Q4 2017.

Glenn Welling reported no remaining DexCom position as of Q4 2017 after selling out during the quarter.
Glenn Welling sold 240,000 DexCom shares in Q4 2017, an estimated $2.94M.
Glenn Welling first reported a position in DexCom in Q3 2017 and held it in 1 quarter.
Glenn Welling's DexCom position peaked at $2.94M in Q3 2017.
273 funds tracked by Wall St. Rank held DexCom as of Q4 2017.

Based on Engaged Capital's 13F filing for Q4 2017, filed 14 Feb 2018.